Behind the Counter
  • Share Your Story
  • News
  • Opinion
  • Stories
  • Humour
  • About
  • Real Estate Blog

About That Amputation Risk With Canagliflozin...

7/13/2017

Comments

 
Picture
​I highly recommend a subscription to Pharmacist's Letter. It summarizes the newest info very well.

Pharmacist's Letter Canada recently released an article as part of their July 2017 newsletter.

They have actually released it for free public viewing:

info.therapeuticresearch.com/opa-pharmacists-letter-canada?utm_source=072017opa&utm_medium=em&utm_campaign=opa&content=link1
If you want the short version here it is:

"Amputations, mainly of the toe or mid-foot, are seen in about 6 in 1,000 patients taking canagliflozin per year...compared to about 3 in 1,000 patients per year on other diabetes meds."

"So far, this has only been seen with canagliflozin. But a class effect can’t be ruled out yet with the other flozins...dapagliflozin (Forxiga, etc) or empagliflozin (Jardiance, etc)."

"Advise patients to contact their prescriber immediately if they develop new foot pain or tenderness, sores or ulcers, etc."
Comments

    News Articles

    News that has been personally selected by the Editorial team.

    Archives

    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    August 2018
    July 2018
    June 2018
    April 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016

    Categories

    All

    RSS Feed

© COPYRIGHT 2016 to forever. ALL RIGHTS RESERVED.
  • Share Your Story
  • News
  • Opinion
  • Stories
  • Humour
  • About
  • Real Estate Blog